首页>
外国专利>
Mutants of gram negative mucosal bacteria and application thereof in vaccines
Mutants of gram negative mucosal bacteria and application thereof in vaccines
展开▼
机译:革兰氏阴性粘膜细菌突变体及其在疫苗中的应用
展开▼
页面导航
摘要
著录项
相似文献
摘要
It is possible to inactivate the early stage of lipid A synthesis of mucosal gram negative bacteria without compromising cell viability. In particular the lpxA gene in N. meningitidis was mutated and resulting lpxA knockout mutants were found to be completely lipopolysaccharide (LPS)-deficient. The major outer membrane proteins (OMPs) were detected in normal amounts. The finding provides important implications for understanding of structure and biogenesis of the outer membrane. On a practical level, the availability of LPS-deficient mutants of pathogenic mucosal bacteria such as N. meningitidis opens up new avenues to vaccine development. It enables easy isolation of endotoxin-free purified proteins, outer membranes or even whole-cell preparations for use in immunisation.
展开▼